Publications médicales – 2016

Huang J, Zagai U, Hallmans G, Nyrén O, Engstrand L, Stolzenberg-Solomon R, Duell EJ, Overvad K, Katzke VA, Kaaks R, Jenab M, Park JY, Murillo R, Trichopoulou A, Lagiou P, Bamia C, Bradbury KE, Riboli E, Aune D, Tsilidis KK, Capellá G, Agudo A, Krogh V, Palli D, Panico S, Weiderpass E, Tjønneland A, Olsen A, Martínez B, Redondo-Sanchez D, Chirlaque MD, Peeters PH, Regnér S, Lindkvist B, Naccarati A, Ardanaz E, Larrañaga N, Boutron-Ruault MC, Rebours V, Barré A, Bueno-de-Mesquita HB, Ye W.

Int J Cancer. 2016 Dec 29. 

Stroes E, Moulin P, Parhofer KG, Rebours V, Löhr JM, Averna M.

Atheroscler Suppl. 2016 Dec 17. 

Cros J, Bazin D, Kellum A, Rebours V, Daudon M.

C. R. Chimie 19 (2016) 1642-1655. 

Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas. 

Robles EP, Maire F, Cros J, Vullierme MP, Rebours V, Sauvanet A, Aubert A, Dokmak S, Lévy P, Ruszniewski P.

United European Gastroenterol J. 2016 Aug;4(4):580-6.

Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers. 

de Mestier L, Danset JB, Neuzillet C, Rebours V, Cros J, Soufir N, Hammel P.

Endocr Relat Cancer. 2016 Aug 10.

MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors. 

Cros J, Hentic O, Rebours V, Zappa M, Gille N, Theo-Anton N, Vernerey D, Maire F, Levy P, Bedossa P, Paradis V, Hammel P, Ruszniewski P, Couvelard A.

Endocr Relat Cancer. 2016 Jun 28

C-06 – Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer? 

O Faille D, Ajzenberg N, de Chaisemartin L, Granger V, Chollet-Martin S, de Raucourt E, Hammel P, Lévy P, Ruszniewski P, Rebours V.

Thromb Res. 2016 Apr;140 Suppl 1:S170-1.

Early biliary complications following pancreaticoduodenectomy: prevalence and risk factors. 

Malgras B, Duron S, Gaujoux S, Dokmak S, Aussilhou B, Rebours V, Palazzo M, Belghiti J, Sauvanet A.

HPB (Oxford). 2016 Apr;18(4):367-74. 

High occurrence of myelodysplasia after chemotherapy and 177Lu octreotate PRRT. 

Brieau B, Hentic O, Lebtahi R, Palazzo M, Ben Reguiga M, Rebours V, Maire F, Hammel P, Ruszniewski P, Fenaux P.

Endocr Relat Cancer. 2016 Mar 1.

 

Diagnostic strategy and timing of intervention in infected necrotizing pancreatitis: an international expert survey and case vignette study. 

an Grinsven J, van Brunschot S, Bakker OJ, Bollen TL, Boermeester MA, Bruno MJ, Dejong CH, Dijkgraaf MG, van Eijck CH, Fockens P, van Goor H, Gooszen HG, Horvath KD, van Lienden KP, van Santvoort HC, Besselink MG; Dutch Pancreatitis Study Group. 

HPB (Oxford). 2016 Jan;18(1):49-56. 

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis. 

Crippa S, Bassi C, Salvia R, Malleo G, Marchegiani G, Rebours V, Levy P, Partelli S, Suleiman SL, Banks PA, Ahmed N, Chari ST, Fernández-Del Castillo C, Falconi M.

Gut. 2016 Jan 7.

Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. 

Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, Marchegiani G, Bassi C, Salvia R, Malleo G, Paiella S, Wolfgang CL, Matthaei H, Offerhaus GJ, Adham M, Bruno MJ, Reid MD, Krasinskas A, Klöppel G, Ohike N, Tajiri T, Jang KT, Roa JC, Allen P, Fernández-del Castillo C, Jang JY, Klimstra DS, Hruban RH; Members of Verona Consensus Meeting, 2013.

Ann Surg. 2016 Jan;263(1):162-77.

Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.

Cavin JB, Couvelard A, Lebtahi R, Ducroc R, Arapis K, Voitellier E, Cluzeaud F, Gillard L, Hourseau M, Mikail N, Ribeiro-Parenti L, Kapel N, Marmuse JP, Bado A, Le Gall M. 

Gastroenterology. 2016 Feb;150(2):454-64.

Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer.

Quemener C, Baud J, Boyé K, Dubrac A, Billottet C, Soulet F, Darlot F, Dumartin L, Sire M, Grepin R, Daubon T, Rayne F, Wodrich H, Couvelard A, Pineau R, Schilling M, Castronovo V, Sue SC, Clarke K, Lomri A, Khatib AM, Hagedorn M, Prats H, Bikfalvi A. 

Cancer Res. 2016 Nov 15;76(22):6507-6519. 

Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature. 

Gilles ME, Maione F, Cossutta M, Carpentier G, Caruana L, Di Maria S, Houppe C, Destouches D, Shchors K, Prochasson C, Mongelard F, Lamba S, Bardelli A, Bouvet P, Couvelard A, Courty J, Giraudo E, Cascone I. 

Cancer Res. 2016 Dec 15;76(24):7181-7193.

de Mestier L, Pasmant E, Fleury C, Brixi H, Sohier P, Féron T, Diebold MD, Clauser E, Cadiot G; Groupe d’Étude des Tumeurs Endocrines. Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing. Dig Liver Dis. 2017 Jan;49(1):98-102. doi: 10.1016/j.dld.2016.10.007. Epub 2016 Oct 20. PubMed PMID: 27825921.

de Boissieu P, Crespel C, Duminil L, de Mestier L. Impact of Depression in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive  Surgery. J Clin Oncol. 2016 Oct 1;34(28):3482. doi: 10.1200/JCO.2016.68.1593. Epub 2016 Jul 25. PubMed PMID: 27458305.

Moryoussef F, de Mestier L, Belkebir M, Deguelte-Lardière S, Brixi H, Kianmanesh R, Hoeffel C, Cadiot G. Impact of Liver and Whole-Body Diffusion-Weighted MRI for Neuroendocrine Tumors on Patient Management: A Pilot Study. Neuroendocrinology. 2017;104(3):264-272. doi: 10.1159/000446369. Epub 2016 Apr 28. PubMed PMID: 27120316.

Lardière-Deguelte S, de Mestier L, Appéré F, Vullierme MP, Zappa M, Hoeffel C, Noaves M, Brixi H, Hentic O, Ruszniewski P, Cadiot G, Panis Y, Kianmanesh R. Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery.  Neuroendocrinology. 2016;103(5):552-9. doi: 10.1159/000441423. Epub 2015 Oct 8. PubMed PMID: 26445315.

 

Cros J, Moati E, Raffenne J, Hentic O, Svrcek M, de Mestier L, Sbidian E, Guedj N, Bedossa P, Paradis V, Sauvanet A, Panis Y, Ruszniewski P, Couvelard A, Hammel P. Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors. Neuroendocrinology. 2016;103(5):495-9. doi: 10.1159/000440724. Epub 2015 Sep 4. PubMed PMID: 26335532.

 

Hammel P, Neuzillet C, Bendaoud S, Lekhal C, de Mestier L, Hentic O. [Pancreatic adenocarcinoma: 10 years of progress]. Bull Cancer. 2015 Jun;102(6 Suppl 1):S62-71. doi: 10.1016/S0007-4551(15)31219-4. Review. French. PubMed PMID: 26118879.

Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery.

Lardière-Deguelte S, de Mestier L, Appéré F, Vullierme MP, Zappa M, Hoeffel C, Noaves M, Brixi H, Hentic O, Ruszniewski P, Cadiot G, Panis Y, Kianmanesh R.

Neuroendocrinology. 2016;103(5):552-9. doi: 10.1159/000441423. Epub 2015 Oct 8.

PMID: 26445315

Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors.

Cros J, Moati E, Raffenne J, Hentic O, Svrcek M, de Mestier L, Sbidian E, Guedj N, Bedossa P, Paradis V, Sauvanet A, Panis Y, Ruszniewski P, Couvelard A, Hammel P.

Neuroendocrinology. 2016;103(5):495-9. doi: 10.1159/000440724. Epub 2015 Sep 4.

PMID: 26335532

Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort.

Pietrasz D, Marthey L, Wagner M, Blanc JF, Laurent C, Turrini O, Raoul JL, Terrebonne E, Hentic O, Trouilloud I, Coriat R, Regenet N, Innominato P, Taieb J, Cunha AS, Bachet JB.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1196-205. doi: 10.1245/s10434-015-4783-x. Epub 2015 Aug 14.

PMID: 26271395